Gregg Duncan, Ph.D.

University of Maryland-College Park
A New Way to Monitor Mucus in Obstructive Lung Diseases

Obstructive lung diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease affect millions of people worldwide. People with these diseases suffer from a steady decline in lung function and recurrent worsening of symptoms. Abnormalities in the mucus produced by people with these diseases have been identified as a key contributor to progression and extent of disease. There has been little innovation in diagnostics available to assess these patients. We will use nanotechnology in the design of a novel diagnostic tool to monitor physical changes in mucus associated with the progression of disease. This research may offer a new, highly valuable tool to analyze patients with obstructive lung disease and could potentially improve their outcomes.

Gregg Duncan, Ph.D.
Better Breather Club | Riverside Shore Memorial Hospital
Nassawadox, VA | Mar 26, 2020
Better Breather Club | Riverside Tappahannock Hospital
Tappahannock, VA | Mar 26, 2020